Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Rezolute to Present Results from its Phase 3 sunRIZE Study in ...
Rezolute Stock: A Deluge of Turmoil
Rezolute Announces Positive Data from its Phase 2b (RIZE) Study of ...
A Pivotal Week for Rezolute as Financial and Strategic Events Converge
Rezolute Stock: FDA Fast Track Fuels 2025 Breakout - The Globe and Mail
Rezolute – Rezolute
Rezolute Downgraded to Hold Amid Disappointing Phase 3 Trial Results ...
Rezolute focused on paradigm shift treating DME - BioTuesdays
Rezolute Hits 52-Week High On Ersodetug Progress In UpLIFT And SunRIZE ...
Rezolute Reports Phase 2b Proof of Concept for Rezpegaldesleukin in ...
Rezolute (RZLT) price target decreased by 61.18% to 6.25
Rezolute Stock: FDA Fast Track Fuels 2025 Breakout
Rezolute Stock Sees Upside Potential Amid FDA Breakthrough Designation ...
Rezolute Shares Plunge After Phase 3 Trial of Ersodetug Fails to Meet ...
Rezolute (RZLT.O) Surges 7.3% on KDJ Golden Cross Amid Weak Sector Rotation
Drug developer Rezolute looks at layoffs after late-stage clinical ...
Rezolute Secures $90M in Strategic Financing Amid Positive Clinical ...
Rezolute Completes Enrollment of its Phase 2 Study in Diabetic Macular ...
Rezolute (NASDAQ:RZLT) CEO Purchases $50,880.00 in Stock
Rezolute Completes Enrollment for Phase 3 sunRIZE Study, Unlocking ...
Rezolute announces initiation of a phase 2 study of RZ402 in patients ...
Rezolute (RZLT.O) Surges 7.32%: A Technical and Order-Flow Deep Dive
Rezolute 'Thrilled' With Positive Review Of Genetic Disorder Trial ...
Rezolute CFO Makes Bold Investment Amid Promising Clinical Progress
Rezolute Phase 3 sunRIZE Trial in Congenital HI Misses Endpoints | RZLT ...
Rezolute Reveals Plans for Upcoming Investor Conferences ...
Rezolute Announces Equity Inducement Grants for New Employees
Recruitment for Rezolute Pediatric Trial | Citeline
Rezolute (RZLT.O) Spikes 6.65% Despite No New Fundamentals: Here’s What ...
HOME - Rezolute
Rezolute Stock Soars 35.98% on Positive Trial Data
Rezolute CEO and Founder to speak at conferences | Rezolute, Inc ...
Rezolute (RZLT) Shares Plummet 89% After Phase 3 Trial Setback
Rezolute (RZLT.O) Spikes 6.5% – What’s Driving the Move?
Fillable Online REZOLUTE, INC. - Rezolute Bio Fax Email Print - pdfFiller
Rezolute Aligns With FDA on Streamlined Ersodetug Trial
Rezolute stock plunges on trial failure (RZLT:NASDAQ) | Seeking Alpha
Rezolute enrol infants, children and adults with congenital HI in ...
Rezolute stock plunges after Phase 3 trial misses primary endpoint By ...
Rezolute stock sinks 87% as hypoglycemia drug fails phase 3 test
Rezolute to Host Virtual Investor Event on Ersodetug Development ...
Rezolute (RZLT) Ends Fiscal 2024 with $127M in Cash to Drive Clinical ...
Rezolute hires ex-Ultragenyx exec for rare disease launch
Rezolute Shares Collapse 90% After Late-Stage Study Misses Primary ...
Rezolute Shares Tanks as Phase 3 Study in Congenital Hyperinsulinism ...
Rezolute FDA Aligns on Simplified Phase 3 Trial for Tumor HI Drug ...
Rezolute kicking off phase 2 study of RZ402 in patients diagnosed with ...
Rezolute starts key Phase 3 trial for RZ358 to treat Congenital ...
Xoma crumbles and partner Rezolute collapses on failed insulin disease drug
Rezolute makes $130M to take disease drug into pivotal trial
Rezolute Stock Negative EV Opportunity Initiatin Phase 3 Ultra-Orphan ...
4pk- Rezolute IPA | Drafting Table Brewing Company
Rezolute – Bridging the gap between business and technology
RZLT (Rezolute Inc.) drops 2.26% after Q1 2026 earnings report reveals ...
IJAN vs BBC — ETF Comparison (2026)
“Hetimet po zvarriten, rezolutë për SPAK”/ Xhaxhai i Aleks Nikës ndihmë ...
Rezolutë kundër dhunë ndaj grave në politikë/ Vokshi në Asamblenë e ...
Rezolute, Inc. - Common Stock (NV) (RZLT) Stock Price, News, Quote ...
Rezolute, Inc.'s Downfall: Share Prices Plummet and Securities Fraud ...
Rezolute, Inc. shares fall 2.46% after-hours following presentation of ...
Rezolute, Inc. shares rise 1.81% intraday after registering a secondary ...
Rezolute's Phase 2 trial of RZ402 shows significant CST reduction in
Rezolute, Inc. (RZLT): Analysts See 260% Upside Potential
Brian Roberts Net Worth, Biography, and Insider Trading
Rezolute's 87% Plunge: A Biotech Meltdown Amid Failed Trial Drama
Rezolute, Inc. shares rise 2.42% intraday after announcing presentation ...
Rezolute, Inc. (RZLT) Discusses Clinical Progress and Market ...
Rezolute: Phase 3 sunRIZE Data For Ersodetug Warrants Downgrade To Sell ...
Rezolute, Inc. (RZLT): Business Model Canvas – DCFmodeling.com
Rezolute's Streamlined FDA-Aligned Phase 3 Trial Design for Ersodetug ...
Rezolute's 89% Plunge: A Biotech Meltdown Amid Clinical Setback
Rezolute's Stock Plummets 88%: A Rare Disease Drug's Failed Trial ...
Rezolute, Inc.: Strategic Positioning in the Evolving Healthcare ...
Rezolute’s Sudden Surge: What Lies Ahead?
Stempoint Capital LP Takes $2.88 Million Position in Rezolute, Inc. $RZLT
Rezolute’s Strategic Advances in Rare Disease Therapies - TipRanks.com
Rezolute, Inc. on LinkedIn: Today we announced the close of a public ...
Rezolute, Inc. (RZLT): A Biotech Breakthrough Poised for Explosive Growth
Rezolute, Inc. on LinkedIn: Today, we reported our fiscal Q3 results ...
Rezolute, Inc. on LinkedIn: #icymi #diabeticmacularedema # ...
Rezolute, Inc. on LinkedIn: #rarediseaseday #rarediseases # ...
Rezolute, Inc. on LinkedIn: Today we reported our Q2 fiscal 2024 ...
Rezolute, Inc. on LinkedIn: Join us in NYC at the Jefferies Global ...
Rezolute's FDA Breakthrough: A New Era for Hypoglycemia Treatment
Rezolute, Inc. on LinkedIn: #diabeticmacularedema #rz402 #dme
Rezolute, Inc. on LinkedIn: #corevalues #metabolicdiseases
Why Rezolute’s Stock Skyrocketed?
Rezolute: Late-Stage Study Targeting Hyperinsulinism (NASDAQ:RZLT ...
Rezolute, Inc. on LinkedIn: This morning we announced the validation of ...
Rezolute, Inc. on LinkedIn: We are thrilled to receive FDA clearance of ...
Rezolute, Inc. on LinkedIn: #raredisease #biotech
Rezolute, Inc. on LinkedIn: #congenitalhyperinsulinism #hi #rz358
Rezolute, Inc. on LinkedIn: #diabeticmacularedema #congenitalhyperinsulism
Rezolute, Inc. on LinkedIn: Read in full here: https://lnkd.in/e3t-cDnV
Rezolute, Inc. on LinkedIn: #diabeticmacularedema #cantor # ...
Jefferies Raises Rezolute’s Price Target Amid Promising Drug Prospects
Rezolute, Inc. on LinkedIn: Early anti-VEGF treatment of diabetic ...
Rezolute, Inc. on LinkedIn: We look forward to participating in the ...
Rezolute, Inc. on LinkedIn: We’re thrilled to have been able to ...
Rezolute, Inc. on LinkedIn: Today, we announced the closing of an ...
Rezolute, Inc. on LinkedIn: Read in full here: https://lnkd.in/gCmv3CKG
#interns #biotech #careerdevelopment | Rezolute, Inc.
Rezolute, Inc. on LinkedIn: #congenitalhyperinsulinism
Rezolute, Inc. on LinkedIn: #mlkday #diversityandinclusion #equity # ...
Why We Specialize in WordPress: The Ultimate CMS for Scalability and ...
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of ...
New Oral Treatment for Metabolic Diseases Diabetic Retinopathy and ...
REZOLUTE, Moscow - District Central (TsAO) - Restaurant Reviews, Photos ...
#rezolute #lead #schoolleaders #learningoutcomes #professionalgrowth # ...
Hussain Alsaffar on LinkedIn: #rezolute #sunrize #clinicaltrial # ...
ProofPilot is LIVE with Rezolute, Inc., Terns Pharmaceuticals, Geneos ...
Rezolute’s stock plunges 87% after hypoglycemia drug flunks pivotal ...
Rezolute, Inc. on LinkedIn: #diabeticmacularedema #diabetic #dme #dme
Maxim Group LLC on LinkedIn: Rezolute, Inc. (RZLT) Announces Pricing of ...
#rezolute #gujaratteam #glimpse #rezolute #lead #leadership # ...
